| 1 | Calpastatin, a calpain specific inhibitor, reduce seizures in a mouse model of temporal lobe epilepsy | 2.8 | 0 | Citations (PDF) |
| 2 | Profiling lamina specific pyramidal neurons using postmortem human formalin fixed paraffin embedded frontal cortex tissue in combination with digital spatial profiling | 2.2 | 0 | Citations (PDF) |
| 3 | Increased Neuronal Expression of the Early Endosomal Adaptor APPL1 Replicates Alzheimer’s Disease-Related Endosomal and Synaptic Dysfunction with Cholinergic Neurodegeneration | 3.7 | 1 | Citations (PDF) |
| 4 | Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases | 78.2 | 205 | Citations (PDF) |
| 5 | Autophagy–lysosomal-associated neuronal death in neurodegenerative disease | 9.2 | 57 | Citations (PDF) |
| 6 | Pathophysiologic abnormalities in transgenic mice carrying the Alzheimer disease <i>PSEN1</i> Δ440 mutation | 2.9 | 0 | Citations (PDF) |
| 7 | Posttranscriptional regulation of neurofilament proteins and tau in health and disease | 3.4 | 14 | Citations (PDF) |
| 8 | Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques | 17.0 | 537 | Citations (PDF) |
| 9 | Autolysosomal acidification failure as a primary driver of Alzheimer disease pathogenesis | 13.7 | 25 | Citations (PDF) |
| 10 | The three-dimensional landscape of cortical chromatin accessibility in Alzheimer’s disease | 17.0 | 51 | Citations (PDF) |
| 11 | Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration | 13.7 | 53 | Citations (PDF) |
| 12 | Post-Golgi carriers, not lysosomes, confer lysosomal properties to pre-degradative organelles in normal and dystrophic axons | 6.3 | 89 | Citations (PDF) |
| 13 | Alzheimer disease | 47.2 | 1,991 | Citations (PDF) |
| 14 | Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies | 2.7 | 254 | Citations (PDF) |
| 15 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 | 13.7 | 2,296 | Citations (PDF) |
| 16 | A gene toolbox for monitoring autophagy transcription | 8.5 | 105 | Citations (PDF) |
| 17 | Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer’s Disease | 6.3 | 106 | Citations (PDF) |
| 18 | The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases | 2.0 | 128 | Citations (PDF) |
| 19 | Neurofilaments: neurobiological foundations for biomarker applicationsBrain, 2020, 143, 1975-1998 | 8.4 | 286 | Citations (PDF) |
| 20 | β2-adrenergic Agonists Rescue Lysosome Acidification and Function in PSEN1 Deficiency by Reversing Defective ER-to-lysosome Delivery of ClC-7 | 4.1 | 33 | Citations (PDF) |
| 21 | Lysosome trafficking and signaling in health and neurodegenerative diseases | 5.1 | 251 | Citations (PDF) |
| 22 | mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy | 8.5 | 103 | Citations (PDF) |
| 23 | Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) | 3.7 | 146 | Citations (PDF) |
| 24 | Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy <i>in vivo</i> | 13.7 | 78 | Citations (PDF) |
| 25 | Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease | 3.7 | 154 | Citations (PDF) |
| 26 | Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors | 5.2 | 52 | Citations (PDF) |
| 27 | Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing | 79.9 | 496 | Citations (PDF) |
| 28 | Cyclodextrin has conflicting actions on autophagy flux
in vivo
in brains of normal and Alzheimer model mice | 2.9 | 30 | Citations (PDF) |
| 29 | Neurofilaments and Neurofilament Proteins in Health and Disease | 7.2 | 667 | Citations (PDF) |
| 30 | Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease | 0.6 | 352 | Citations (PDF) |
| 31 | Calpastatin inhibits motor neuron death and increases survival of hSOD1G93A mice | 3.8 | 43 | Citations (PDF) |
| 32 | Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders | 3.4 | 81 | Citations (PDF) |
| 33 | Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy | 13.7 | 319 | Citations (PDF) |
| 34 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | 13.7 | 4,989 | Citations (PDF) |
| 35 | Presenilin 1 Maintains Lysosomal Ca2+ Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification | 6.3 | 333 | Citations (PDF) |
| 36 | Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease | 4.0 | 73 | Citations (PDF) |
| 37 | Dissociation of Axonal Neurofilament Content from Its Transport Rate | 2.3 | 13 | Citations (PDF) |
| 38 | Spared Piriform Cortical Single-Unit Odor Processing and Odor Discrimination in the Tg2576 Mouse Model of Alzheimer's Disease | 2.3 | 18 | Citations (PDF) |
| 39 | Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice | 3.7 | 96 | Citations (PDF) |
| 40 | 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease | 0.5 | 67 | Citations (PDF) |
| 41 | Alzheimer neurodegeneration, autophagy, and Abeta secretion: The ins and outs (comment on DOI 10.1002/bies.201400002) | 2.1 | 14 | Citations (PDF) |
| 42 | Single-Walled Carbon Nanotubes Alleviate Autophagic/Lysosomal Defects in Primary Glia from a Mouse Model of Alzheimer’s Disease | 8.7 | 124 | Citations (PDF) |
| 43 | Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficitsBrain, 2014, 137, 3300-3318 | 8.4 | 105 | Citations (PDF) |
| 44 | The role of autophagy in neurodegenerative disease | 33.0 | 1,906 | Citations (PDF) |
| 45 | Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model | 3.4 | 36 | Citations (PDF) |
| 46 | Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis | 13.7 | 141 | Citations (PDF) |
| 47 | Global Axonal Transport Rates are Unaltered in Htau Mice in vivo | 2.6 | 14 | Citations (PDF) |
| 48 | Peripherin Is a Subunit of Peripheral Nerve Neurofilaments: Implications for Differential Vulnerability of CNS and Peripheral Nervous System Axons | 3.7 | 115 | Citations (PDF) |
| 49 | The Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease | 6.6 | 162 | Citations (PDF) |
| 50 | Neurofilaments at a glance | 2.4 | 368 | Citations (PDF) |
| 51 | Calpastatin modulates APP processing in the brains of β-amyloid depositing but not wild-type mice | 3.4 | 14 | Citations (PDF) |
| 52 | Autophagy and Neuronal Cell Death in Neurological Disorders | 7.2 | 169 | Citations (PDF) |
| 53 | Guidelines for the use and interpretation of assays for monitoring autophagy | 13.7 | 3,229 | Citations (PDF) |
| 54 | The C-Terminal Domains of NF-H and NF-M Subunits Maintain Axonal Neurofilament Content by Blocking Turnover of the Stationary Neurofilament Network | 2.3 | 35 | Citations (PDF) |
| 55 | Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease | 2.0 | 123 | Citations (PDF) |
| 56 | Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments | 3.4 | 46 | Citations (PDF) |
| 57 | Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease | 3.7 | 16 | Citations (PDF) |
| 58 | Autophagy failure in Alzheimer's disease—locating the primary defect | 5.1 | 616 | Citations (PDF) |
| 59 | Lysosomal Proteolysis Inhibition Selectively Disrupts Axonal Transport of Degradative Organelles and Causes an Alzheimer's-Like Axonal Dystrophy | 3.7 | 433 | Citations (PDF) |
| 60 | Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficitsBrain, 2011, 134, 258-277 | 8.4 | 419 | Citations (PDF) |
| 61 | The Myosin Va Head Domain Binds to the Neurofilament-L Rod and Modulates Endoplasmic Reticulum (ER) Content and Distribution within Axons | 2.3 | 46 | Citations (PDF) |
| 62 | Regional Selectivity of rab5 and rab7 Protein Upregulation in Mild Cognitive Impairment and Alzheimer's Disease | 2.6 | 119 | Citations (PDF) |
| 63 | Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition | 7.5 | 285 | Citations (PDF) |
| 64 | Rapamycin induces autophagic flux in neurons | 7.5 | 38 | Citations (PDF) |
| 65 | Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy | 2.9 | 220 | Citations (PDF) |
| 66 | Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression | 5.4 | 252 | Citations (PDF) |
| 67 | The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models | 4.4 | 21 | Citations (PDF) |
| 68 | Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 MutationsCell, 2010, 141, 1146-1158 | 33.7 | 1,124 | Citations (PDF) |
| 69 | Cystatin C Rescues Degenerating Neurons in a Cystatin B-Knockout Mouse Model of Progressive Myoclonus Epilepsy | 3.4 | 55 | Citations (PDF) |
| 70 | Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis | 3.7 | 259 | Citations (PDF) |
| 71 | Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines | 2.3 | 112 | Citations (PDF) |
| 72 | Complexes of Amyloid-β and Cystatin C in the Human Central Nervous System | 2.6 | 31 | Citations (PDF) |
| 73 | Chapter 6 Monitoring Autophagy in Alzheimer's Disease and Related Neurodegenerative Diseases | 2.1 | 34 | Citations (PDF) |
| 74 | Neurofilaments Form a Highly Stable Stationary Cytoskeleton after Reaching a Critical Level in Axons | 3.7 | 102 | Citations (PDF) |
| 75 | Age‐dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model | 3.8 | 84 | Citations (PDF) |
| 76 | In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model | 3.4 | 52 | Citations (PDF) |
| 77 | Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease | 3.7 | 1,071 | Citations (PDF) |
| 78 | Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology | 3.4 | 183 | Citations (PDF) |
| 79 | Neuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease | 3.4 | 162 | Citations (PDF) |
| 80 | Marked Calpastatin (CAST) Depletion in Alzheimer's Disease Accelerates Cytoskeleton Disruption and Neurodegeneration: Neuroprotection by CAST Overexpression | 3.7 | 100 | Citations (PDF) |
| 81 | Neurodegenerative lysosomal disorders: A continuum from development to late age | 13.7 | 341 | Citations (PDF) |
| 82 | Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease | 10.6 | 200 | Citations (PDF) |
| 83 | Cortical Plasticity in Alzheimer’s Disease in Humans and Rodents | 5.4 | 169 | Citations (PDF) |
| 84 | Cystatin C inhibits amyloid-β deposition in Alzheimer's disease mouse models | 25.2 | 178 | Citations (PDF) |
| 85 | Neuronal macroautophagy: From development to degeneration | 9.4 | 156 | Citations (PDF) |
| 86 | Deleting the phosphorylated tail domain of the neurofilament heavy subunit does not alter neurofilament transport rate in vivo | 1.9 | 43 | Citations (PDF) |
| 87 | Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration | 11.0 | 522 | Citations (PDF) |
| 88 | Autophagy in neurodegenerative disease: friend, foe or turncoat? | 9.7 | 315 | Citations (PDF) |
| 89 | Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease | 2.6 | 221 | Citations (PDF) |
| 90 | -Internexin Is Structurally and Functionally Associated with the Neurofilament Triplet Proteins in the Mature CNS | 3.7 | 217 | Citations (PDF) |
| 91 | Histological Co-Localization of Iron in A� Plaques of PS/APP Transgenic Mice | 3.4 | 119 | Citations (PDF) |
| 92 | Autophagy and Its Possible Roles in Nervous System Diseases, Damage and Repair | 13.7 | 432 | Citations (PDF) |
| 93 | Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study | 1.8 | 1,420 | Citations (PDF) |
| 94 | Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases | 3.4 | 381 | Citations (PDF) |
| 95 | Medical bioremediation: Prospects for the application of microbial catabolic diversity to aging and several major age-related diseases | 11.6 | 34 | Citations (PDF) |
| 96 | Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease | 5.4 | 959 | Citations (PDF) |
| 97 | Amyloid-β Deposition Is Associated with Decreased Hippocampal Glucose Metabolism and Spatial Memory Impairment in APP/PS1 Mice | 1.8 | 114 | Citations (PDF) |
| 98 | Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F2-isoprostanes in the absence of detectable amyloid deposits | 3.8 | 41 | Citations (PDF) |
| 99 | Overexpression of Human Cystatin C in Transgenic Mice Does Not Affect Levels of Endogenous Brain Amyloid β Peptide | 2.4 | 25 | Citations (PDF) |
| 100 | MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease | 2.8 | 110 | Citations (PDF) |
| 101 | Visualization of ?-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents | 2.8 | 100 | Citations (PDF) |
| 102 | Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for β-amyloid peptide over-production and localization in Alzheimer’s disease | 2.6 | 290 | Citations (PDF) |
| 103 | Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome | 3.4 | 363 | Citations (PDF) |
| 104 | Calpain Mediates Calcium-Induced Activation of the Erk1,2 MAPK Pathway and Cytoskeletal Phosphorylation in Neurons | 3.4 | 127 | Citations (PDF) |
| 105 | Presenilin Mutations in Familial Alzheimer Disease and Transgenic Mouse Models Accelerate Neuronal Lysosomal Pathology | 1.8 | 148 | Citations (PDF) |
| 106 | Calpain Inhibitors, a Treatment for Alzheimer's Disease: Position Paper | 2.4 | 64 | Citations (PDF) |
| 107 | Title is missing! | 3.4 | 59 | Citations (PDF) |
| 108 | The calpains in aging and aging-related diseases | 11.6 | 206 | Citations (PDF) |
| 109 | The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate | 5.4 | 118 | Citations (PDF) |
| 110 | Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular β-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and Aβ Production | 2.2 | 213 | Citations (PDF) |
| 111 | Neurofilament TransportIn VivoMinimally Requires Hetero-Oligomer Formation | 3.7 | 51 | Citations (PDF) |
| 112 | Alzheimer's Disease-related Overexpression of the Cation-dependent Mannose 6-Phosphate Receptor Increases Aβ Secretion | 2.2 | 93 | Citations (PDF) |
| 113 | Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density | 5.4 | 107 | Citations (PDF) |
| 114 | Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein | 2.2 | 98 | Citations (PDF) |
| 115 | Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport | 5.4 | 131 | Citations (PDF) |
| 116 | P301L tauopathy | 2.1 | 26 | Citations (PDF) |
| 117 | Calpain inhibitors | 2.4 | 53 | Citations (PDF) |
| 118 | Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2 | 9.2 | 101 | Citations (PDF) |
| 119 | Multiple-label immunocytochemistry for the evaluation of nature of cell death in experimental models of neurodegeneration | 1.6 | 27 | Citations (PDF) |
| 120 | The neuronal endosomal-lysosomal system in Alzheimer's disease | 2.6 | 114 | Citations (PDF) |
| 121 | Endocytic disturbances distinguish among subtypes of alzheimer's disease and related disorders | 6.6 | 84 | Citations (PDF) |
| 122 | Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease | 37.9 | 1,505 | Citations (PDF) |
| 123 | Title is missing! | 3.4 | 316 | Citations (PDF) |
| 124 | Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo | 5.4 | 149 | Citations (PDF) |
| 125 | Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down Syndrome | 3.4 | 831 | Citations (PDF) |
| 126 | Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL | 3.4 | 80 | Citations (PDF) |
| 127 | A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease | 4.0 | 93 | Citations (PDF) |
| 128 | Isoform-specific translocation of protein kinase C following glutamate administration in primary hippocampal neurons | 2.6 | 25 | Citations (PDF) |
| 129 | Developmental regulation of the recovery process following glutamate-induced calcium rise in rodent primary neuronal cultures | 2.1 | 20 | Citations (PDF) |
| 130 | The slow axonal transport debate | 12.1 | 18 | Citations (PDF) |
| 131 | Dynamic behavior and organization of cytoskeletal proteins in neurons: reconciling old and new findings | 2.1 | 63 | Citations (PDF) |
| 132 | Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death | 2.6 | 66 | Citations (PDF) |
| 133 | The slow axonal transport of cytoskeletal proteins | 3.9 | 92 | Citations (PDF) |
| 134 | Immunocytochemistry of formalin-fixed human brain tissues: microwave irradiation of free-floating sections | 1.6 | 33 | Citations (PDF) |
| 135 | Caspase-Mediated Fragmentation of Calpain Inhibitor Protein Calpastatin during Apoptosis | 2.8 | 250 | Citations (PDF) |
| 136 | The Proteolytic Fragments of the Alzheimer's Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex | 2.2 | 307 | Citations (PDF) |
| 137 | Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau | 2.5 | 37 | Citations (PDF) |
| 138 | Triton-soluble phosphovariants of the heavy neurofilament subunit in developing and mature mouse central nervous system | 3.1 | 35 | Citations (PDF) |
| 139 | Cellular Expression and Proteolytic Processing of Presenilin Proteins Is Developmentally Regulated During Neuronal Differentiation | 3.8 | 81 | Citations (PDF) |
| 140 | Colocalization of Lysosomal Hydrolase and β-Amyloid in Diffuse Plaques of the Cerebellum and Striatum in Alzheimerʼs Disease and Downʼs Syndrome | 1.8 | 72 | Citations (PDF) |
| 141 | Calcium Influx into Human Neuroblastoma Cells Induces ALZ‐50 Immunoreactivity: Involvement of Calpain‐Mediated Hydrolysis of Protein Kinase C | 3.8 | 55 | Citations (PDF) |
| 142 | Aluminum treatment of intact neuroblastoma cells alters neurofilament subunit phosphorylation, solubility, and proteolysis | 0.9 | 15 | Citations (PDF) |
| 143 | Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system | 11.0 | 359 | Citations (PDF) |
| 144 | The endosomal-lysosomal system of neurons: new roles | 9.7 | 150 | Citations (PDF) |
| 145 | Proteolysis of protein kinase C: mM and μM calcium-requiring calpains have different abilities to generate, and degrade the free catalytic subunit, protein kinase M | 2.7 | 64 | Citations (PDF) |
| 146 | Purification and Properties of High Molecular Weight Calpastatin from Bovine Brain | 3.8 | 19 | Citations (PDF) |
| 147 | Enhancement of Neurite Outgrowth Following Calpain Inhibition Is Mediated by Protein Kinase C | 3.8 | 42 | Citations (PDF) |
| 148 | [32P]orthophosphate and [35S]methionine label separate pools of neurofilaments with markedly different axonal transport kinetics in mouse retinal ganglion cells in vivo | 3.4 | 29 | Citations (PDF) |
| 149 | Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease | 2.5 | 46 | Citations (PDF) |
| 150 | Free radicals, proteolysis, and the degeneration of neurons in alzheimer disease: How essential is the β-amyloid link? | 3.4 | 33 | Citations (PDF) |
| 151 | Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease | 2.5 | 216 | Citations (PDF) |
| 152 | Differential Expression and Subcellular Localization of Protein Kinase C ?, ?, ?, ?, and ? Isoforms in SH-SY5Y Neuroblastoma Cells: Modifications During Differentiation | 3.8 | 75 | Citations (PDF) |
| 153 | Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human ?CANP and mCANP | 3.4 | 25 | Citations (PDF) |
| 154 | The Lysosomal System in Neuronal Cell Death: A Review | 4.0 | 84 | Citations (PDF) |
| 155 | The Regulation of Neurofilament Protein Dynamics by Phosphorylation: Clues to Neurofibrillary Pathobiology | 5.0 | 157 | Citations (PDF) |
| 156 | Aluminum Alters the Electrophoretic Properties of Neurofilament Proteins: Role of Phosphorylation State | 3.8 | 43 | Citations (PDF) |
| 157 | Distinct Mechanisms of Differentiation of SH-SY5Y Neuroblastoma Cells by Protein Kinase C Activators and Inhibitors | 3.8 | 54 | Citations (PDF) |
| 158 | Immunoassay and Activity of Calcium-Activated Neutral Proteinase (mCANP): Distribution in Soluble and Membrane-Associated Fractions in Human and Mouse Brain | 3.8 | 25 | Citations (PDF) |
| 159 | Dynamics of neuronal intermediate filaments: A developmental perspective | 3.8 | 212 | Citations (PDF) |
| 160 | Neurofilament phosphorylation: a new look at regulation and function | 9.7 | 308 | Citations (PDF) |
| 161 | Multiple Proteases Regulate Neurite Outgrowth in NB2a/dl Neuroblastoma Cells | 3.8 | 49 | Citations (PDF) |
| 162 | Dynamics of Phosphorylation and Assembly of the High Molecular Weight Neurofilament Subunit in NB2a/d1 Neuroblastoma | 3.8 | 58 | Citations (PDF) |
| 163 | Aluminum Inhibits Calpain-Mediated Proteolysis and Induces Human Neurofilament Proteins to Form ProteaseResistant High Molecular Weight Complexes | 3.8 | 74 | Citations (PDF) |
| 164 | Post-translational modification of α-tubulin by acetylation and detyrosination in NB2a/d1 neuroblastoma cells | 2.1 | 18 | Citations (PDF) |
| 165 | Fluoxetine Versus Trazodone in Depressed Geriatric Patients | 0.9 | 58 | Citations (PDF) |
| 166 | Early posttranslational modifications of the three neurofilament subunits in mouse retinal ganglion cells: neuronal sites and time course in relation to subunit polymerization and axonal transport | 2.6 | 77 | Citations (PDF) |
| 167 | Appearance and localization of phosphorylated variants of the high molecular weight neurofilament protein in NB2a/d1 cytoskeletons during differentiation | 2.1 | 26 | Citations (PDF) |
| 168 | Calcium-Activated Neutral Proteinases as Regulators of Cellular Function Implications for Alzheimer's Disease Pathogenesis | 4.0 | 71 | Citations (PDF) |
| 169 | Aluminum salts induce the accumulation of neurofilaments in perikarya of NB2a/dl neuroblastoma | 2.5 | 59 | Citations (PDF) |
| 170 | Phosphorylation of neurofilament proteins by protein kinase C | 2.7 | 66 | Citations (PDF) |
| 171 | Neurofilament triplet proteins of NB2a/d1 neuroblastoma: posttranslational modification and incorporation into the cytoskeleton during differentiation | 2.1 | 63 | Citations (PDF) |
| 172 | Differential distribution of vimentin and neurofilament protein immunoreactivity in NB2a/d1 neuroblastoma cells following neurite retraction distinguishes two separate intermediate filament systems | 2.1 | 17 | Citations (PDF) |
| 173 | Soluble, phosphorylated forms of the high molecular weight neurofilament protein in perikarya of cultured neuronal cells | 1.9 | 32 | Citations (PDF) |
| 174 | Cerebrospinal fluid levels of angiotensin- converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: A correlative study | 5.4 | 72 | Citations (PDF) |
| 175 | A versatile transition metal salt reaction for a wide range of common biochemical reagents: An instantaneous and quantifiable color test | 2.4 | 3 | Citations (PDF) |
| 176 | Calcium‐Activated Neutral Proteinase of Human Brain: Subunit Structure and Enzymatic Properties of Multiple Molecular Forms | 3.8 | 48 | Citations (PDF) |
| 177 | Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue | 1.9 | 6 | Citations (PDF) |
| 178 | Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy | 2.5 | 90 | Citations (PDF) |
| 179 | Degradation of Neurofilament Proteins by Purified Human Brain Cathepsin D | 3.8 | 86 | Citations (PDF) |
| 180 | Proteases of human brain | 3.4 | 40 | Citations (PDF) |
| 181 | Limited proteolytic modification of a neurofilament protein involves a proteinase activated by endogenous levels of calcium | 2.5 | 51 | Citations (PDF) |
| 182 | Protease activities in normal and schizophrenic human prefrontal cortex and white matter | 3.4 | 10 | Citations (PDF) |
| 183 | Characterization and Comparison of Neurofilament Proteins from Rat and Mouse CNS | 3.8 | 64 | Citations (PDF) |
| 184 | Protein degradation in the mouse visual system I. Degradation of axonally transported and retinal proteins | 2.5 | 76 | Citations (PDF) |
| 185 | Uptake and metabolism of intraventricularly administered piperidine and its effects on sleep and wakefulness in the rat | 2.5 | 7 | Citations (PDF) |
| 186 | Neurotoxicity of a non-metabolizable amino acid, 1-aminocyclopentane-1-carboxylic acid (ACPC): ACPC transport mechanisms in tissues | 5.1 | 4 | Citations (PDF) |
